Pertento Partners’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.5M Buy
373,970
+49,548
+15% +$6.08M 2.6% 16
2025
Q4
$53.4M Buy
324,422
+54,001
+20% +$7.16M 5.02% 9
2025
Q3
$27.9M Buy
+270,421
New +$26.5M 3.24% 14

Other funds holding NUTX

Pertento Partners's NUTX Position: Q1 2026 in Review

Pertento Partners increased its Nutex Health (NUTX) stake by 15% in Q1 2026, buying an estimated $6.08M and bringing the position to 373,970 shares worth $35.5M. The position accounts for 2.6% of the portfolio, ranked #16.

Pertento Partners first reported a position in NUTX in Q3 2025 and has held it in 3 quarters since. The position peaked at $53.4M in Q4 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Pertento Partners held 373,970 shares of Nutex Health worth $35.5M as of Q1 2026.
  • Pertento Partners bought 49,548 Nutex Health shares in Q1 2026, an estimated $6.08M.
  • Nutex Health made up 2.6% of Pertento Partners's portfolio in Q1 2026, its #16 holding.
  • Pertento Partners first reported a position in Nutex Health in Q3 2025 and has held it in 3 quarters since.
  • Pertento Partners's Nutex Health position peaked at $53.4M in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Pertento Partners's 13F filing for Q1 2026, filed 14 May 2026.